Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
of particle and astro-particle physics Analyse and interpret research findings and results Contribute to generating funding Main Duties The responsibilities may include some but not all of the list outlined
-
would be an advantage Experience performing and analysing experiments with gamma-ray and charged-particle spectroscopy would be an advantage. Particularly knowledge of Coulomb excitation and/ or gamma-ray
-
contributions In addition: Experience with data analysis using the ROOT analysis package would be an advantage Experience performing and analysing experiments with gamma-ray and charged-particle spectroscopy
-
which will quantify and develop a mechanistic understanding of how environmental controls drive fine sediment impacts for freshwater biota. Fine sediment (typically defined as particles <2mm) deposition
-
North Atlantic atmosphere (ANAA). As part of this research, SEANA studies the sources and processes of aerosol particles, including from primary sources such as shipping or ocean, and formation
-
, 268002 (2021)]. We will use innovative experimental techniques employing particle tracking of model 2D vibrated particles to test fundamental theoretical concepts in statistical physics. The successful
-
, Sherwood, The300). The Astronomy group shares research interests with the Nottingham Particle Cosmology group housed in the same building. You will also have collaboration opportunities with other groups in
-
, The300). The Astronomy group shares research interests with the Nottingham Particle Cosmology group housed in the same building. You will also have significant collaboration opportunities with other groups
-
particle image velocimetry, hotwire anemometry and pressure measurements. The work will also involve close collaboration with consortium partners. The candidate will be required to work closely with other
-
translated eleven vaccine candidates, including viral vectors, recombinant proteins-in-adjuvants and a virus-like particle, into Phase 1 and 2 clinical trials in the UK and Africa. Over half of these trials